ABCG2 and cancer: To determine if P-gp or ABCG2 expression would confer resistance to ensartinib, cytotoxicity assays were performed on several pairs of drug-sensitive cancer cell lines and the corresponding drug-resistant cell lines overexpressing either P-gp or ABCG2.